IndraLab

Statements


USP9X inhibits RAS. 1 / 1
| 1

reach
"Ostensibly in the above pre-clinical contexts, loss of USP9X stabilizes YAP therefore indirectly enhancing RAS driven oncogenesis through YAP activation."